RU2577965C2 - Способ идентификации иммунных связывающих веществ поверхностных антигенов клетки - Google Patents

Способ идентификации иммунных связывающих веществ поверхностных антигенов клетки Download PDF

Info

Publication number
RU2577965C2
RU2577965C2 RU2011124039/10A RU2011124039A RU2577965C2 RU 2577965 C2 RU2577965 C2 RU 2577965C2 RU 2011124039/10 A RU2011124039/10 A RU 2011124039/10A RU 2011124039 A RU2011124039 A RU 2011124039A RU 2577965 C2 RU2577965 C2 RU 2577965C2
Authority
RU
Russia
Prior art keywords
cells
antigen
cell
expressing
immune
Prior art date
Application number
RU2011124039/10A
Other languages
English (en)
Russian (ru)
Other versions
RU2011124039A (ru
Inventor
Валери ХУЛЬМАН-КОТЬЕ
Дэвид УРЕХ
Original Assignee
ИЭсБиЭйТЕК, ЭН АЛЬКОН БАЙОМЕДИКАЛ РИСЕРЧ ЮНИТ ЭлЭлСи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CH2009/000222 external-priority patent/WO2009155726A2/en
Application filed by ИЭсБиЭйТЕК, ЭН АЛЬКОН БАЙОМЕДИКАЛ РИСЕРЧ ЮНИТ ЭлЭлСи filed Critical ИЭсБиЭйТЕК, ЭН АЛЬКОН БАЙОМЕДИКАЛ РИСЕРЧ ЮНИТ ЭлЭлСи
Priority claimed from PCT/CH2010/000044 external-priority patent/WO2010096941A1/en
Publication of RU2011124039A publication Critical patent/RU2011124039A/ru
Application granted granted Critical
Publication of RU2577965C2 publication Critical patent/RU2577965C2/ru

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/5052—Cells of the immune system involving B-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
RU2011124039/10A 2009-02-24 2010-02-22 Способ идентификации иммунных связывающих веществ поверхностных антигенов клетки RU2577965C2 (ru)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US15510509P 2009-02-24 2009-02-24
US15504109P 2009-02-24 2009-02-24
US61/155,041 2009-02-24
US61/155,105 2009-02-24
CH832/09 2009-06-02
CH8322009 2009-06-02
CHPCT/CH2009/000222 2009-06-25
PCT/CH2009/000222 WO2009155726A2 (en) 2008-06-25 2009-06-25 Humanization of rabbit antibodies using a universal antibody framework
PCT/CH2010/000044 WO2010096941A1 (en) 2009-02-24 2010-02-22 Methods for identifying immunobinders of cell-surface antigens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2016103262A Division RU2635186C2 (ru) 2009-02-24 2016-02-02 Способы идентификации иммунных связующих веществ поверхностных антигенов клетки

Publications (2)

Publication Number Publication Date
RU2011124039A RU2011124039A (ru) 2012-12-20
RU2577965C2 true RU2577965C2 (ru) 2016-03-20

Family

ID=48917567

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2011124039/10A RU2577965C2 (ru) 2009-02-24 2010-02-22 Способ идентификации иммунных связывающих веществ поверхностных антигенов клетки
RU2017135831A RU2017135831A (ru) 2009-02-24 2017-10-09 Способы идентификации иммунных связующих веществ поверхностных антигенов клетки

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2017135831A RU2017135831A (ru) 2009-02-24 2017-10-09 Способы идентификации иммунных связующих веществ поверхностных антигенов клетки

Country Status (12)

Country Link
JP (3) JP6161655B2 (ja)
KR (4) KR101817279B1 (ja)
CN (1) CN105116138A (ja)
BR (1) BRPI1005398A2 (ja)
CL (1) CL2011001453A1 (ja)
ES (1) ES2618181T3 (ja)
IL (4) IL226955A (ja)
MX (1) MX352922B (ja)
PH (1) PH12014502468B1 (ja)
RU (2) RU2577965C2 (ja)
SG (3) SG10201708233VA (ja)
ZA (1) ZA201103125B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110016462B (zh) * 2019-02-20 2020-04-24 优睿赛思(武汉)生物科技有限公司 从脾脏细胞中高效分离单个抗原特异性b淋巴细胞的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63253098A (ja) * 1987-04-10 1988-10-20 Ube Ind Ltd ヒト抗体に対するモノクロ−ナル抗体、その製法及び用途
IL91948A (en) 1988-10-26 1994-05-30 Immunomedics Removal of immunoreactive components from a sample
US5417972A (en) * 1993-08-02 1995-05-23 The Board Of Trustees Of The Leland Stanford Junior University Method of killing B-cells in a complement independent and an ADCC independent manner using antibodies which specifically bind CDIM
KR0119909B1 (ko) * 1993-10-05 1997-10-20 김은영 플로우 사이토미터를 이용한 고상형 면역 측정방법
EP1709970A1 (en) * 1995-04-27 2006-10-11 Abgenix, Inc. Human antibodies against EGFR, derived from immunized xenomice
ATE253593T1 (de) * 1996-07-16 2003-11-15 Plueckthun Andreas Prof Dr Immunglobulin-superfamilie domainen und fragmente mit erhöhter löslichkeit
DK1506236T3 (da) * 2002-05-22 2013-03-04 Esbatech A Novartis Co Llc Immunglobulin-frameworks, der udviser forbedret stabilitet i det intracellulære miljø og fremgangsmåder til identifikation deraf
CN1396182A (zh) * 2002-07-31 2003-02-12 陕西超英生物医学研究开发有限公司 人内皮生长因子受体2蛋白全人单克隆抗体及其制备方法
AU2003264009A1 (en) 2002-08-15 2004-03-03 Epitomics, Inc. Humanized rabbit antibodies
CA2505924A1 (en) * 2002-11-13 2004-05-27 Micromet Ag Method for identifying antigen specific b cells
JP4336812B2 (ja) * 2003-03-07 2009-09-30 博夫 岩田 細胞に発現する表面抗原を迅速に同定するための分析方法
US20070087331A1 (en) * 2003-05-15 2007-04-19 Cytos Biotechnology Ag Selection of b cells with specificity if interest: method of preparation and use
CN100415765C (zh) 2003-08-07 2008-09-03 宜康公司 兔单克隆抗体的人源化方法
CA2655511C (en) * 2005-07-01 2017-03-21 John Schrader Methods of isolating cells and generating monoclonal antibodies
US20070134249A1 (en) 2005-12-08 2007-06-14 Genitope Corporation Combination therapy and antibody panels
KR101363695B1 (ko) * 2005-12-28 2014-02-14 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 항페리오스틴에 대한 항체, 및 페리오스틴이 관여하는 질환의 예방 또는 치료를 위해 그것을 함유하는 약제학적 조성물
MY159787A (en) * 2006-06-02 2017-01-31 Regeneron Pharma High affinity antibodies to human il-6 receptor
WO2008004834A1 (en) * 2006-07-06 2008-01-10 Isu Abxis Co., Ltd Humanized monoclonal antibody highly binding to epidermal growth factor receptor, egf receptor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BURKE J., MANN. C. "Rapid isolation of monoclonal antibody producing cell lines." BioProcess International (2006), Supp.: 48-51. ERDILE L. F. et al., "Whole cell ELISA for detection of tumor antigen expression in tumor samples." Journal of immunological methods (2001); 258(1): 47-53. TAJIRI K. et al., "Cell-microarray analysis of antigen-specific B-cells: single cell analysis of antigen receptor expression and specificity." Cytometry A. (2007); 71(11):961-967. EFFROS R. et al., "Detection of antibodies to cell surface antigens by a simplified cellular ELISA (CELISA)." Tissue antigens (1985); 25(4): 204-211. ARUNACHALAM B.G. et al., "A simplified cellular ELISA (CELISA) for the detection of antibodies reacting with cell-surface antigens." Journal of immunological methods (1990); 135(1): 181-189. BROWNE S. M., AL-RUBEAI М. "Selection methods for high-producing mammalian cell lines." Trends in biotechnology (2007); 25(9): 425-432. *

Also Published As

Publication number Publication date
MX352922B (es) 2017-12-14
KR20190020202A (ko) 2019-02-27
ZA201103125B (en) 2012-08-29
RU2011124039A (ru) 2012-12-20
KR20180005752A (ko) 2018-01-16
PH12014502468A1 (en) 2016-01-18
ES2618181T3 (es) 2017-06-21
RU2017135831A3 (ja) 2019-04-09
IL263158A (en) 2018-12-31
IL237985B (en) 2018-12-31
CN105116138A (zh) 2015-12-02
PH12014502468B1 (en) 2016-01-18
RU2017135831A (ru) 2019-04-09
KR20160022397A (ko) 2016-02-29
JP6604989B2 (ja) 2019-11-13
JP6161655B2 (ja) 2017-07-12
CL2011001453A1 (es) 2012-02-24
IL226956A (en) 2015-04-30
SG2014014864A (en) 2014-09-26
KR101817279B1 (ko) 2018-01-10
IL226955A0 (en) 2013-07-31
IL263158B (en) 2019-10-31
KR20160150642A (ko) 2016-12-30
JP2015146825A (ja) 2015-08-20
BRPI1005398A2 (pt) 2019-03-26
KR102059866B1 (ko) 2019-12-27
IL226955A (en) 2015-04-30
JP2017192384A (ja) 2017-10-26
SG10201408247SA (en) 2015-02-27
JP2018196395A (ja) 2018-12-13
IL226956A0 (en) 2013-07-31
SG10201708233VA (en) 2017-11-29
KR101689791B1 (ko) 2016-12-26

Similar Documents

Publication Publication Date Title
RU2635186C2 (ru) Способы идентификации иммунных связующих веществ поверхностных антигенов клетки
US20190382498A1 (en) Humanized immunobinders of cell-surface antigens
JP2011528905A (ja) 抗体レパートリーアレイ（ａｒａ）を使用する標的特異的抗体を発見するための方法および組成物
JP6604989B2 (ja) 細胞表面抗原のイムノバインダーを同定するための方法
AU2018204035B2 (en) Methods for identifying immunobinders of cell-surface antigens
AU2013203478B2 (en) Methods for identifying immunobinders of cell-surface antigens
US20240101710A1 (en) B-cell maturation antigen (bcma) anti-idiotypic antibodies
CN117136306A (zh) 用于预测生物制剂的药代动力学和脑渗透性的体外基于细胞的测定

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner
PC41 Official registration of the transfer of exclusive right

Effective date: 20220323